Running News and Research

RSS

Underwriters' exercise over-allotment option in Senior Housing Properties Trust's secondary offering

Senior Housing Properties Trust today announced that the underwriters of its secondary offering have exercised, in full, their over-allotment option to purchase an additional 1,875,000 shares of beneficial interest, raising additional net proceeds of approximately $36.8 million. The settlement of the over-allotment option is expected to occur on December 15, 2010.

13 Dec 2010

Research programs embody the promise of anti-aging medicine.

Sometimes the value of research lies as much in exposing false remedies as in discovering true breakthroughs. Scientists at the country's first school of gerontology and in laboratories around the University of Southern California do both, mindful of their responsibility to a society focused on healthful aging.

13 Dec 2010

Arizona's transplant funding cuts continue to trigger controversy; Florida, Kansas focus on state role in reforms; Wisc. plan would elminate tax on health savings accounts

[Arizona Gov. Jane] Brewer's transplant cutbacks have become a rallying cause for Democrats, who call her decision "Brewercare." It's hypocritical for Republicans to support the program's end while opposing President Barack Obama's health-care legislation on the ground it would create death panels run by bureaucrats, said Anna Tovar, a Democratic state representative from Tolleson (Palmeri, 12/10).

10 Dec 2010

GOP lawmaker calls government funding bill a 'trojan horse' for health reform

Politics continue to swirl around health overhaul and deficit reduction issues. A new Bloomberg poll, for instance, indicates that the public wants the deficit addressed, but still wants Congress to stay away from Medicare, Medicaid and other entitlement programs. Meanwhile, a GOP senator targets the catch-all spending bill to fund the government as a "trojan horse" to fund the health overhaul. Off the hill, groups are paying particular attention to the words used in discussing health policy issues.

10 Dec 2010

Aastrom Biosciences prices public offering

Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that it has priced a public offering of 10,000,000 units, with each unit consisting of one share of the Company's common stock and one warrant to purchase one share of common stock, at a purchase price of $2.25 per unit for an aggregate offering amount of $22.5 million.

10 Dec 2010

Weightlifting may help prevent lymphedema following breast cancer treatment

Weightlifting may play a key role in the prevention of the painful limb-swelling condition lymphedema following breast cancer treatment, according to new research from the University of Pennsylvania School of Medicine. Combined with the team's previous findings that the exercise limits a worsening of symptoms among women who already have lymphedema, the new data cements the reversal of long-running advice that breast cancer survivors should avoid lifting anything heavier than five pounds after they finish treatment.

10 Dec 2010

HeartWare prices public offering of convertible senior notes due 2017

HeartWare International, Inc. announced today the pricing of a public offering of $125 million principal amount of convertible senior notes due 2017 (the "notes") pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC") yesterday.

10 Dec 2010

HeartWare announces $100 million convertible senior notes offering

HeartWare International, Inc. announced today its intention to offer, subject to market and other conditions, $100 million principal amount of convertible senior notes due 2017 (the "notes") pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC") today. HeartWare also intends to grant the underwriters an option to purchase up to an additional $15 million principal amount of notes to cover over-allotments, if any.

9 Dec 2010

Study to develop ways to track individual's exposure to traffic pollution

Researchers at King's College London are developing ways of working out a person's individual exposure to traffic pollution when travelling to, from, and around London.

9 Dec 2010

Momenta prices underwritten public offering

Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the pricing of an underwritten public offering of 4,000,000 shares of its common stock at $14.35 per share. The total proceeds, before expenses, to Momenta will be approximately $57.4 million. The offering is expected to close on December 13, 2010, subject to customary closing conditions.

8 Dec 2010

Lung transplant saves economist from near-lethal bout of swine flu

According to the critical care experts at The Johns Hopkins Hospital who treated him, Allen Bagents, 24, of Arlington, Va., is the least likely person anyone ever expects to get sick, let alone suffer a six-week, potentially fatal bout with the swine flu, better known as H1N1 influenza.

8 Dec 2010

Financial Times contrasts 'bottom up' and 'top down' approaches to developing country drugs

The Financial Times contrasts the model of drug development for developing countries being used by non-profit groups like the Meningitis Vaccine Project (MVP), which recently rolled out the MenAfriVac, to that of some pharmaceutical companies.

8 Dec 2010

Conn. addresses insurance rates, Mass. physician groups evaluate controversial payment plan

"House and Senate leaders are eyeing passage of a second midyear spending bill before the start of the next legislative session to address more caseload-driven accounts that are running short on funds five months after Gov. Deval Patrick signed the fiscal 2011 budget. The deficiencies, which follow inaccurate enrollment estimates for MassHealth and other social service programs, threaten to eat into some the revenue surpluses the state has amassed over the first half of fiscal 2011, when tax receipts have exceeded projections" (Murphy, 12/7).

8 Dec 2010

Fluxion Biosciences announces launch of new BioFlux 1000Z system for live cell imaging

Fluxion Biosciences, Inc. announced that the new BioFlux 1000Z system for live cell imaging will be launched at the 50th American Society for Cell Biology Annual Meeting to be held December 11-15, 2010 in Philadelphia, PA. The BioFlux 1000Z is the latest addition to the BioFlux product family of instruments for cellular analysis under controlled shear flow.

From Fluxion Biosciences 7 Dec 2010

First Edition: December 7, 2010

In today's headlines, Senate leaders appear to be nearing a one-year deal on Medicare's physician pay problem.

7 Dec 2010

Lytix Biopharma, KAEL-GemVax initiate treatment in LTX-315/GV1001 combination anti-cancer vaccine trial

The Norwegian biopharmaceutical company Lytix Biopharma and the Korean biotechnology company KAEL-GemVax announced today the successful first treatment in the study of a combination of LTX-315 and GV1001 as anti-cancer vaccine therapy.

7 Dec 2010

Broselow Pediatric Emergency Tape now in electronic format

A well-known paper-based medical chart used by pediatric emergency personnel across America is undergoing a 21st century boost in an collaborative effort between Virginia Tech's College of Engineering, Roanoke-based Carilion Clinic Children's Hospital, and the physician who created the original method some 25 years ago.

7 Dec 2010

Research team creates digital version of Broselow tape for children

7 Dec 2010

Annual BioPartnering China conference launched at Renaissance Shanghai Pudong Hotel

The 3rd Annual BioPartnering China conference, co-produced by TVG and the Zhangjiang Biotech Pharmaceutical Base, launched today at the Renaissance Shanghai Pudong Hotel. The conference attracts a global representation of industry leaders from China, Europe and the USA.

6 Dec 2010

Seasonal light cycles can affect development of babies' specific brain function: Study

The season in which babies are born can have a dramatic and persistent effect on how their biological clocks function.

6 Dec 2010

Running News and Research

Underwriters' exercise over-allotment option in Senior Housing Properties Trust's secondary offering

Research programs embody the promise of anti-aging medicine.

Arizona's transplant funding cuts continue to trigger controversy; Florida, Kansas focus on state role in reforms; Wisc. plan would elminate tax on health savings accounts

GOP lawmaker calls government funding bill a 'trojan horse' for health reform

Aastrom Biosciences prices public offering

Weightlifting may help prevent lymphedema following breast cancer treatment

HeartWare prices public offering of convertible senior notes due 2017

HeartWare announces $100 million convertible senior notes offering

Study to develop ways to track individual's exposure to traffic pollution

Momenta prices underwritten public offering

Lung transplant saves economist from near-lethal bout of swine flu

Financial Times contrasts 'bottom up' and 'top down' approaches to developing country drugs

Conn. addresses insurance rates, Mass. physician groups evaluate controversial payment plan

Fluxion Biosciences announces launch of new BioFlux 1000Z system for live cell imaging

First Edition: December 7, 2010

Lytix Biopharma, KAEL-GemVax initiate treatment in LTX-315/GV1001 combination anti-cancer vaccine trial

Broselow Pediatric Emergency Tape now in electronic format

Research team creates digital version of Broselow tape for children

Annual BioPartnering China conference launched at Renaissance Shanghai Pudong Hotel

Seasonal light cycles can affect development of babies' specific brain function: Study

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News